We examined the expression of immune checkpoint components in both tumor-infiltrating immune cells, i.e., CD4 T, CD8 T, NK, and Treg cells, and the complementary antigen-presenting cells (APCs), i.e., macrophages and tumor cells. Here, CD4 is linked to neoplasm.